© BusinessWire
24.10.2024
HELP
LISTED
NASDAQ
Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that the United States Patent and Trademark Office (“USPTO”) has granted U.S. pa...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2024
DFTX
LISTED
NASDAQ
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it plans to host a conference call on Thursday, November 7, 2024, at 4:30 p.m. ET to provide a corporate update and review the Company’s resul...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2024
LEGN
LISTED
NASDAQ
Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
News Preview
SOMERSET, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, November 12, 2024, to review third-quarter 2024 results....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
24.10.2024
ZLAB
LISTED
NASDAQ
ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung Cancer
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today presented data from the ongoing global Phase 1a/1b study of ZL-1310, a potential best-in-class next-generation antibody-drug conjugate (ADC), at the EORTC-NCI-AACR (ENA) Symposium 2024 in Barcelona, Spain, as an oral presentation during the plenary session. ZL-1310 is being tested in patients with p...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
24.10.2024
DEDI
LISTED
STO
Dedicare's Interim Report 1 January - 30 September 2024: Market still challenging in the third quarter
News Preview
STOCKHOLM, Oct. 24, 2024 /PRNewswire/ --
Third quarter 2024
Net sales SEK 460.9 million (524.5)EBITA SEK 11.2 million (40.6), adjusted for non-recurring items SEK 19.0 million (40.6)EBITA margin 2.4 percent (7.7), adjusted for non-recurring items 4.1 percent (7.7)EBIT SEK 9.0 million (36.7), adjusted for non-recurring items SEK 16.8 million (36...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
ORX
LISTED
STO
Orexo Interim Report Q3 2024
News Preview
UPPSALA, Sweden, Oct. 24, 2024 /PRNewswire/ --
Q3 2024 highlights
› Total net revenues of SEK 136.5 m (156.1)
› EBITDA of SEK -0.7 m (-9.5)
› Net earnings of SEK -41.9 m (-33.3)
› US Commercial segment net revenues of SEK 131.0 m (140.4), in local currency USD 12.6 m (13.0)
› Cash flow from operating activities of SEK -13.4 m (-21.9), cash...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
SOBI
LISTED
STO
Sobi Q3 2024 report: Strong growth and significant pipeline momentum
News Preview
STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter 2024
Third Quarter 2024
Total revenue increased 33 per cent, 39 per cent at constant exchange rates, (CER)1, to SEK 6,894 M (5,168)Haematology revenue increased 18 per cent at CER to SEK 4,000 M (3,484), mainly dri...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
ORX
LISTED
STO
Orexo Interim Report Q3 2024
News Preview
UPPSALA, Sweden, Oct. 24, 2024 /PRNewswire/ --
Q3 2024 highlights
› Total net revenues of SEK 136.5 m (156.1)
› EBITDA of SEK -0.7 m (-9.5)
› Net earnings of SEK -41.9 m (-33.3)
› US Commercial segment net revenues of SEK 131.0 m (140.4), in local currency USD 12.6 m (13.0)
› Cash flow from operating activities of SEK -13.4 m (-21.9), cash...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
SOBI
LISTED
STO
Sobi Q3 2024 report: Strong growth and significant pipeline momentum
News Preview
STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter 2024
Third Quarter 2024
Total revenue increased 33 per cent, 39 per cent at constant exchange rates, (CER)1, to SEK 6,894 M (5,168)Haematology revenue increased 18 per cent at CER to SEK 4,000 M (3,484), mainly dri...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
BIOA B
LISTED
STO
Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD
News Preview
STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) founder Lars Lannfelt will be presented with the Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research at the Clinical Trials for Alzheimer's Disease Conference (CTAD) held in Madrid, Spain, and virtually from October 29 to November 1. Lars...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
VITR
LISTED
STO
Vitrolife AB Interim report Q3, 2024: Improved growth with solid margins
News Preview
GOTHENBURG, Sweden, Oct. 24, 2024 /PRNewswire/ --
Third quarter
Sales of SEK 867 (848) million, an increase of 7% in local currencies and 2% in SEK.Sales per region, in local currencies was +9% in EMEA, +2% in Americas and +9% in APAC.Sales per business area, in local currencies was +13% in Consumables, +11% in Technologies and 0% in Genetics....
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
BIOA B
LISTED
STO
Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD
News Preview
STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) founder Lars Lannfelt will be presented with the Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research at the Clinical Trials for Alzheimer's Disease Conference (CTAD) held in Madrid, Spain, and virtually from October 29 to November 1. Lars...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
24.10.2024
INDV
LISTED
NASDAQ
Indivior Announces Q3 2024 Financial Results
News Preview
SLOUGH, United Kingdom and RICHMOND, Va., Oct. 24, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending September 30, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.
The earnings release can be found at www.indivior.com/investorsThe inves...
Themefolio
Profiler
Peergroup
© PR Newswire
24.10.2024
INDV
LISTED
NASDAQ
Indivior Announces Q3 2024 Financial Results
News Preview
SLOUGH, United Kingdom and RICHMOND, Va., Oct. 24, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending September 30, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com....
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2024
ICLR
LISTED
NASDAQ
ICON Reports Third Quarter 2024 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the third quarter ended September 30, 2024.
CEO, Dr. Steve Cutler commented, “ICON’s results for the third quarter did not meet the expectations we had previously provided due to specific customer and divis...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2024
SLP
LISTED
NASDAQ
Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today reported financial results for its fourth quarter and fiscal 2024, ended August 31, 2024.
Fourth Quarter 2024 Financial Highlights (c...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2024
EVT
LISTED
XETR
Evotec and Bristol Myers Squibb expand proteomics partnership
News Preview
Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology
Evotec receives a US$ 50 m payment from Bristol Myers Squibb; potential programme-based milestone payments contribute to the deal value
Hamburg, Germany, 23 October 2024:
Evotec SE (Frankfurt Stock Exchange: EV......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.10.2024
EVT
LISTED
XETR
Evotec und Bristol Myers Squibb erweitern Proteomics-Partnerschaft
News Preview
Wichtige wissenschaftliche Erfolge treiben den Ausbau der Pipeline von Molecular Glue Degraders in Bereichen außerhalb der Onkologie voran
Evotec erhält eine Zahlung von 50 Mio. US$ von Bristol Myers Squibb; potenzielle programmbezogene Meilensteinzahlungen tragen zum Wert der Vereinbarung bei
Hamburg, 23 Oktober 2024:
Evotec ......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.10.2024
EVT
LISTED
XETR
Evotec and Bristol Myers Squibb Expand Proteomics Partnership
News Preview
Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncologyEvotec receives a US$ 50 m payment from Bristol Myers Squibb; potential programme-based milestone payments contribute to the deal value HAMBURG, GERMANY / ACCESSWIRE / October 23, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2024
DBV
LISTED
EURONEXT
DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe
News Preview
Châtillon, France, October 22, 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2024
CHEMM
LISTED
CPH
Closing of acquisition of Ovizio Imaging Systems SA
News Preview
ANNOUNCEMENT NO. 281...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2024
CYRX
LISTED
NASDAQ
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
News Preview
Partnership Coincides with the Grand Opening of Cryoport's State-Of-The-Art IntegriCell™ Houston Facility
NASHVILLE, Tenn. and HOUSTON, Oct. 22, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and Gulf Coast Regional Blood Center ("GCRBC"), a non-profit com...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2024
CYRX
LISTED
NASDAQ
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
News Preview
Two ISO-Certified Industry Leaders Collaborate to Provide Fertility Clinics with Complete, Trusted Solutions for Secure IVF Specimen Management and Transport
NASHVILLE, Tenn. and NEW YORK, Oct. 21, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and TMRW L...
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2024
AMRX
LISTED
NASDAQ
Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company based in the U.S., today announced that it has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for Pyridostigmine Bromide Extended-Release (PB ER) Tablets USP 105 mg.
PB ER 105 mg tablets are a once-...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2024
COLO B
LISTED
CPH
Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET
News Preview
Tuesday, 5 November 2024 at 11.00 – 12.00 CETIn connection with the publication of Coloplast's interim financial results for FY 2023/24 the company will host a conference call to present the financial results and answer questions from investors and financial analysts.A presentation will be available on Coloplast's website approximately 1 hour befor...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2024
NSIS B
LISTED
CPH
New employee-elected board member
News Preview
Company announcement No. 42...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2024
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Completes Enrollment of Clinical Outcomes Study of Resmetirom in Patients with Compensated NASH/MASH Cirrhosis
News Preview
CONSHOHOCKEN, Pa., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH)/metabolic dysfunction-associated steatohepatitis (MASH), today announced the MAESTRO-NASH OUTCOMES trial evaluating resmetirom for the treat...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.10.2024
SKYE
LISTED
NASDAQ
Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences
News Preview
SAN DIEGO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, today announced that it will participate in the following upcoming healthcare investment conferences:...
Themefolio
Profiler
Peergroup
© PR Newswire
21.10.2024
RAY B
LISTED
STO
Invitation to presentation of RaySearch's interim report for the third quarter of 2024
News Preview
STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the third quarter of 2024 on November 8, 2024, at 10.00 am CET. The report will be published on November 8, 2024, at 07.45 am and will be available together with presentation slides on raysearchlabs.com. Joha...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.10.2024
DBV
LISTED
EURONEXT
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
News Preview
Châtillon, France, October 18, 2024...
Themefolio
Profiler
Peergroup
© Newsfile
18.10.2024
COPN
LISTED
SIX
Cosmo Shareholders Approved Board Proposal to Appoint New Independent Auditor at Today's EGM
News Preview
Dublin, Ireland--(Newsfile Corp. - October 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) shareholders today approved the proposal by the Board of Directors to appoint Deloitte Accountants B.V. as new independent auditor of the Company for the financial year ending on 31 December 2024. Co...
Themefolio
Profiler
Peergroup
© BusinessWire
18.10.2024
ZLAB
LISTED
NASDAQ
Zai Lab Announces Participation in November and December Investor Conferences
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November and December 2024:
Goldman Sachs APAC Healthcare Corporate Day 2024
Time: November 5-8, 2024
Location: Hong Kong, Hong Kong
Jefferies London Healthcare Conference
Fir...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.10.2024
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024
News Preview
CONSHOHOCKEN, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its third-quarter 2024 financial results on Thursday, Oct. 31, 2024, prior to the open of the U.S. financial markets....
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2024
GETI B
LISTED
STO
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings
News Preview
GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased by 3.5%, of which the organic increase was 0.2%, while the operating margin weakened...
Themefolio
Profiler
Peergroup
© PR Newswire
18.10.2024
GETI B
LISTED
STO
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings
News Preview
GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased by 3.5%, of which the organic increase was 0.2%, while the operating margin weakened...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2024
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice Recognized as an Age-Friendly Health Systems Participant
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its recognition by the Institute for Healthcare Improvement (IHI) as an Age-Friendly Health Systems Participant.
Age-friendly Health Systems Participants are recognized for being on the journey to becoming an Age-Friendly Health System and have submitted a des...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2024
OSE
LISTED
EURONEXT
OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for the Design of Cytokine Drugs with Improved Therapeutic Index
News Preview
NANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting its novel OSE-CYTOMASK Cis-Demasking1 cytokine technology in oral presentations selected for international conferences:...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2024
ZLAB
LISTED
NASDAQ
Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will hold an investor webcast to discuss data from a Phase 1 clinical trial of ZL-1310, the Company’s investigational DLL3-targeted antibody-drug conjugate (ADC), in patients with advanced stage small cell lung cancer (SCLC). The live conference call and webcast will take place on...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.10.2024
DIM
LISTED
EURONEXT
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024
News Preview
Sartorius Stedim Biotech SA
/ Key word(s): 9 Month figures
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024 17-Oct-2024 / 07:02 CET/CEST
Aubagne, France | October 17, 2024Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2024
Sales revenue of 2,029 mill......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.10.2024
SRT3
LISTED
XETR
sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow
News Preview
Göttingen, Germany | October 17, 2024
Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow
Group sales revenue down only slightly by - 2.0 percent after nine months; order intake up 6.6 percent
Underlying EBITDA margin reaches 27.7 percent; further i......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.10.2024
SRT3
LISTED
XETR
Umsatz fast auf Vorjahr; Aufträge legen zu; robuste Profitabilität; gesteigerter Cashflow
News Preview
Göttingen, 17. Oktober 2024
9-Monatszahlen im Rahmen der Erwartungen: Umsatz fast auf Vorjahr; Aufträge legen zu; robuste Profitabilität; gesteigerter Cashflow
Konzernumsatz nach neun Monaten mit – 2,0 Prozent nur noch leicht rückläufig, Auftragseingang plus 6,6 Prozent
Operative Ertragsmarge erreicht 27,7 Prozent, weiter zunehmende positive E......
Themefolio
Profiler
Peergroup
© Globe Newswire
17.10.2024
KDEV
LISTED
STO
Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific conference, INBC 2024
News Preview
STOCKHOLM, SWEDEN – October 17, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition will present new preclinical data on golexanolone, showing retained dopamine signalling in Parkinson’s disease, at the 10th International Conference on Neurology and Brain Disorders 2024 in Baltimore...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
17.10.2024
CLBX
LISTED
AIMX
Angle PLC Announces Publication Demonstrates CTC Profiling Potential
News Preview
PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCERParsortix enriched CTCs detected at high rates in localised diseaseMulti-marker profiling of CTCs could support development of targeted therapies and help stratify patients in clinical trials GUILDFORD, SURREY / ACCESSWIRE / October 17, 2024 / ANGLE plc (AIM:A...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2024
CHEMM
LISTED
CPH
Acquisition of Ovizio Imaging Systems SA
News Preview
ANNOUNCEMENT NO. 280...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2024
CHEMM
LISTED
CPH
Upgrade of revenue and operating profit guidance
News Preview
ANNOUNCEMENT NO. 279...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2024
ZLAB
LISTED
NASDAQ
Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report financial results for the third quarter of 2024 and recent corporate updates, before the opening of the U.S. equity markets on Tuesday, November 12, 2024. The Company will host a live conference call and webcast on the same date, at 8:00 a.m. ET (9:00 p.m. HKT).
Confer...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2024
SN
LISTED
LSE
RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
News Preview
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design Concept 2024 in the Medical Devices and Technology Category, recognizing its intuitive pairing of NPWT housed in a patient-friendly design....
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2024
RAY B
LISTED
STO
Another three centers under the French Unicancer framework select RayStation
News Preview
STOCKHOLM, Oct. 16, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges, have placed orders for the treatment planning system RayStation®* under the Unicancer 2019 Framework agreement.
Unicancer is a French hosp...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.10.2024
AGFB
LISTED
EURONEXT
AGFA HealthCare Set to Unveil 'Next-Generation' Enterprise Imaging with Groundbreaking Innovations at RSNA 2024
News Preview
Empowering Radiologists to Grow, Work, and Live - In BalanceGREENVILLE, SC / ACCESSWIRE / October 16, 2024 / As the demand for medical imaging surges and the mandates for clinical confidence become more defined, so does the need to maintain a high-quality and frustration-free, work-life balance for radiologists. At this year's RSNA annual meeting,...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2024
PHM
LISTED
BME
PharmaMar gibt positive und statistisch signifikante Ergebnisse zum Gesamtüberleben und zum progressionsfreien Überleben für die Kombination aus Zepzelca® (Lurbinectedin) und Atezolizumab in der Erstlinien-Erhaltungstherapie bei kleinzelligem Lungenkrebs
News Preview
Jazz plant die Einreichung eines ergänzenden Zulassungsantrags (sNDA) bei der US-Arzneimittelbehörde (FDA) und PharmaMar wird in der ersten Hälfte des Jahres 2025 bei der Europäischen Arzneimittelagentur (EMA) einen Zulassungsantrag für diese Kombinationstherapie als Erstlinien-Erhaltungstherapie für ES-SCLC einreichen. MADRID, 16. Oktober 2024 /...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please see the attached PDF for details....
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2024
FYB
LISTED
XETR
Formycon published results of analytical similarity study of biosimilar candidate FYB206 and Keytruda® in peer-reviewed journal Drugs in R&D
News Preview
Press Release // October 16, 2024
Formycon published results of analytical similarity study of biosimilar candidate FYB206 and Keytruda® in peer-reviewed journal Drugs in R&D
The comparative analytical evaluation results indicate that the proposed Keytruda®-biosimilar FYB206 is structurally and functionally highly similar to the reference......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2024
FYB
LISTED
XETR
Formycon publiziert Ergebnisse der analytischen Studie zur Vergleichbarkeit des Biosimilarkandidaten FYB206 mit Keytruda® in der Fachzeitschrift Drugs in R&D
News Preview
Pressemitteilung // 16. Oktober 2024
Formycon publiziert Ergebnisse der analytischen Studie zur Vergleichbarkeit des Biosimilar-Kandidaten FYB206 mit Keytruda® in der Fachzeitschrift Drugs in R&D
Ergebnisse der vergleichenden analytischen Bewertung zeigen strukturell und funktionell eine sehr hohe Similarität zwischen dem Referenzprodukt ......
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2024
EAPI
LISTED
EURONEXT
Olivier Falut appointed EUROAPI’s Chief Financial Officer
News Preview
Paris – October 16, 2024 – Olivier Falut has been appointed EUROAPI’s Chief Financial Officer, effective October 17, 2024, and will be a member of the Executive Committee. He is taking over from Evelyne Nguyen, who will remain within the company until the end of October to ensure a smooth transition....
Themefolio
Profiler
Peergroup
© EQS Newswire
15.10.2024
EUZ
LISTED
XETR
Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared to Previous Year
News Preview
3rd quarter of 2024:
Sales of EUR 70.1 million (previous year: EUR 65.9 million)
EBIT before special items of EUR 15.5 million (previous year: EUR 15.1 million)
Net income of EUR 5.3 million (previous year: EUR 9.4 million)
First 9 months of 2024:
Sales of EUR 215.5 million (previous year: EUR 183.9 million)
EBIT before special items of EUR ......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.10.2024
EUZ
LISTED
XETR
Eckert & Ziegler mit anhaltendem Umsatz- und Gewinnwachstum in den ersten 9 Monaten gegenüber Vorjahr
News Preview
3. Quartal 2024:
Umsatz: 70,1 Mio. EUR (VJ: 65,9 Mio. EUR)
EBIT vor Sondereinflüssen: 15,5 Mio. EUR (VJ: 15,1 Mio. EUR)
Nettogewinn: 5,3 Mio. EUR (VJ: 9,4 Mio. EUR)
9-Monatszeitraum 2024:
Umsatz: 215,5 Mio. EUR (VJ: 183,9 Mio. EUR)
EBIT vor Sondereinflüssen: 46,7 Mio. EUR (VJ: 37,7 Mio. EUR)
Nettogewinn: 23,4 Mio. EUR (VJ: 20,3 Mio. EUR)
Jahr......
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2024
PHM
LISTED
BME
PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
News Preview
Jazz plans to submit supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) and PharmaMar will submit Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) in first half of the year 2025 for this combination therapy as a first-line maintenance treatment for ES-SCLC. MADRID, Oct. 15, 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2024
CYRX
LISTED
NASDAQ
VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies
News Preview
Partnership Will Enhance Support for Biopharmaceutical Companies in Developing Cell and Gene Therapies and mRNA-Based Treatments
NASHVILLE, Tenn. and CONROE, Texas, Oct. 15, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences, and VGXI, Inc., (VXGI) a subsidiary of GeneO...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.10.2024
GMAB
LISTED
CPH
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
